1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Medical Research Institution 1.3.3 Hospital and Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2016-2027) 2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions 2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2016-2021) 2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) 2.3 Synthetic Lethality-based Drugs and Targets Industry Dynamic 2.3.1 Synthetic Lethality-based Drugs and Targets Market Trends 2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers 2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges 2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue 3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2016-2021) 3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2016-2021) 3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue 3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio 3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2020 3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served 3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service 3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type 4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2016-2021) 4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) 5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application 5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2016-2021) 5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027) 6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type 6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) 6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) 6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027) 6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application 6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) 6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) 6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027) 6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country 6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) 6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2016-2027) 7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type 7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) 7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) 7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027) 7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application 7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) 7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) 7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027) 7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country 7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) 7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2016-2027) 8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type 8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027) 8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application 8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027) 8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region 8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027) 9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type 9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) 9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) 9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027) 9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application 9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) 9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) 9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027) 9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country 9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) 9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2016-2027) 10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type 10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027) 10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application 10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027) 10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country 10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction 11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.1.5 AbbVie Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction 11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 BeiGene 11.3.1 BeiGene Company Details 11.3.2 BeiGene Business Overview 11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction 11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.3.5 BeiGene Recent Development 11.4 Clovis Oncology 11.4.1 Clovis Oncology Company Details 11.4.2 Clovis Oncology Business Overview 11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction 11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.4.5 Clovis Oncology Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction 11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction 11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 AtlasMedx 11.7.1 AtlasMedx Company Details 11.7.2 AtlasMedx Business Overview 11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction 11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.7.5 AtlasMedx Recent Development 11.8 Chordia Therapeutics 11.8.1 Chordia Therapeutics Company Details 11.8.2 Chordia Therapeutics Business Overview 11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.8.5 Chordia Therapeutics Recent Development 11.9 IDEAYA Biosciences 11.9.1 IDEAYA Biosciences Company Details 11.9.2 IDEAYA Biosciences Business Overview 11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction 11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.9.5 IDEAYA Biosciences Recent Development 11.10 Mission Therapeutics 11.10.1 Mission Therapeutics Company Details 11.10.2 Mission Therapeutics Business Overview 11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.10.5 Mission Therapeutics Recent Development 11.11 Repare Therapeutics 11.11.1 Repare Therapeutics Company Details 11.11.2 Repare Therapeutics Business Overview 11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.11.5 Repare Therapeutics Recent Development 11.12 Sierra Oncology 11.12.1 Sierra Oncology Company Details 11.12.2 Sierra Oncology Business Overview 11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction 11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.12.5 Sierra Oncology Recent Development 11.13 SyntheX Labs 11.13.1 SyntheX Labs Company Details 11.13.2 SyntheX Labs Business Overview 11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction 11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) 11.13.5 SyntheX Labs Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2016-2021) Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027) Table 10. Synthetic Lethality-based Drugs and Targets Market Trends Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2016-2021) Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020) Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021) Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2016-2021) Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million) Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) Table 61. AbbVie Company Details Table 62. AbbVie Business Overview Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 65. AbbVie Recent Development Table 66. AstraZeneca Company Details Table 67. AstraZeneca Business Overview Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 70. AstraZeneca Recent Development Table 71. BeiGene Company Details Table 72. BeiGene Business Overview Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 75. BeiGene Recent Development Table 76. Clovis Oncology Company Details Table 77. Clovis Oncology Business Overview Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 80. Clovis Oncology Recent Development Table 81. GlaxoSmithKline Company Details Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 85. GlaxoSmithKline Recent Development Table 86. Pfizer Company Details Table 87. Pfizer Business Overview Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 90. Pfizer Recent Development Table 91. AtlasMedx Company Details Table 92. AtlasMedx Business Overview Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 95. AtlasMedx Recent Development Table 96. Chordia Therapeutics Company Details Table 97. Chordia Therapeutics Business Overview Table 98. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 99. Chordia Therapeutics Recent Development Table 100. IDEAYA Biosciences Company Details Table 101. IDEAYA Biosciences Business Overview Table 102. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product Table 103. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 104. IDEAYA Biosciences Recent Development Table 105. Mission Therapeutics Company Details Table 106. Mission Therapeutics Business Overview Table 107. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product Table 108. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 109. Mission Therapeutics Recent Development Table 110. Repare Therapeutics Company Details Table 111. Repare Therapeutics Business Overview Table 112. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product Table 113. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 114. Repare Therapeutics Recent Development Table 115. Sierra Oncology Company Details Table 116. Sierra Oncology Business Overview Table 117. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product Table 118. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 119. Sierra Oncology Recent Development Table 120. SyntheX Labs Company Details Table 121. SyntheX Labs Business Overview Table 122. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product Table 123. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million) Table 124. SyntheX Labs Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2027 Figure 2. Monotherapy Features Figure 3. Combination Therapy Features Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2027 Figure 5. Medical Research Institution Case Studies Figure 6. Hospital and Clinic Case Studies Figure 7. Other Case Studies Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2027 Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027) Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2020 Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2020 Figure 16. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021) Figure 17. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027) Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027) Figure 21. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027) Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027) Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027) Figure 27. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027) Figure 28. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027) Figure 36. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027) Figure 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2016-2027) Figure 38. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027) Figure 46. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027) Figure 47. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027) Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027) Figure 52. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027) Figure 53. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027) Figure 54. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 58. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 59. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 60. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 63. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 64. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 65. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 66. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 67. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 68. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 69. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

AbbVie AstraZeneca BeiGene Clovis Oncology GlaxoSmithKline Pfizer AtlasMedx Chordia Therapeutics IDEAYA Biosciences Mission Therapeutics Repare Therapeutics Sierra Oncology SyntheX Labs